DexCom Inc

Затворен

СекторЗдравеопазване

89.69 -1.97

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

89.31

Максимум

89.99

Ключови измерители

By Trading Economics

Приходи

50M

249M

Продажби

117M

1.3B

P/E

Средно за сектора

33.454

57.002

EPS

0.7

Марж на печалбата

19.039

Служители

11,000

EBITDA

52M

389M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+2.07% upside

Дивиденти

By Acuity

Следващи печалби

29.10.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

4.8B

33B

Предишно отваряне

91.66

Предишно затваряне

89.69

Настроения в новините

By Acuity

28%

72%

68 / 340 Класиране в Healthcare

DexCom Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

14.08.2026 г., 19:16 ч. UTC

Dexcom Inc shares are lower today, continuing a decline since Thursday's close amid broader market caution following an unexpected drop in U.S. retail sales.

13.08.2026 г., 19:26 ч. UTC

Dexcom Inc shares are higher today, despite an earlier pullback. The stock's advance contrasts with a broader market decline since the session's start.

12.08.2026 г., 19:36 ч. UTC

Dexcom Inc shares are higher amid broader market optimism following inflation data. The core Consumer Price Index showed a modest increase, aligning with forecasts.

11.08.2026 г., 23:26 ч. UTC

Dexcom Inc shares are trading lower in after-market hours. Broader market trends and cautious investor sentiment may be influencing this price movement.

10.08.2026 г., 20:02 ч. UTC

Dexcom Inc shares are higher today, continuing an upward trend since Friday. The move occurs amid recent labor market data influencing investor sentiment.

7.08.2026 г., 23:46 ч. UTC

Dexcom Inc shares are higher in after-market hours, continuing recent positive momentum. The stock remains well above its 20-day moving average.

5.08.2026 г., 19:51 ч. UTC

News

Dexcom shares are declining amid negative sentiment in the insulin sector following Podd's revenue growth forecast cut. Broader economic data also influences cautious market sentiment.

4.08.2026 г., 19:56 ч. UTC

Dexcom Inc. shares are lower today, pulling back after reaching a session high. The broader market benefits from a significant decline in crude oil prices.

3.08.2026 г., 20:02 ч. UTC

News
Social Media

Dexcom Inc. shares are higher following strong Q2 results and raised revenue guidance to $5.22 billion. Canaccord increased its price target to $90.

31.07.2026 г., 20:04 ч. UTC

News
Social Media

Dexcom Inc. shares are higher following analyst upgrades and strong earnings, with second-quarter revenue of $1.31 billion exceeding expectations and guidance raised to $5.22 billion.

30.07.2026 г., 23:51 ч. UTC

News
Social Media

Dexcom reported second-quarter revenue of $1.308 billion and adjusted EPS of $0.70, raising its fiscal year 2026 revenue guidance, with shares trading higher in after-market hours.

29.07.2026 г., 23:41 ч. UTC

Dexcom Inc is trading higher in after-market hours, supported by overall market strength. The asset remains above its 20-day moving average.

28.07.2026 г., 20:06 ч. UTC

News

Dexcom shares rise after UBS initiated coverage with a Buy rating. The stock is advancing since Monday's close of $73.37 amid positive sentiment in the Health Care Equipment sector.

27.07.2026 г., 19:06 ч. UTC

News

Dexcom Inc. gains Health Canada approval for its Dexcom G7 continuous glucose monitoring system, boosting marketability and user adoption amid positive analyst sentiment.

24.07.2026 г., 15:22 ч. UTC

Dexcom Inc's shares are higher today, driven by gains in the Health Care Equipment sub-sector. No specific company news was identified for the movement.

22.07.2026 г., 20:01 ч. UTC

Dexcom Inc. shares are lower today, continuing a decline since Tuesday. Earlier, the stock briefly rose before pulling back.

21.07.2026 г., 19:26 ч. UTC

Dexcom Inc is trading lower, continuing a trend of three consecutive declines. The stock reached a session low earlier today before a slight recovery.

20.07.2026 г., 19:22 ч. UTC

Dexcom Inc shares are lower amid broader market declines and rising Treasury yields. The stock remains near the upper end of its one-month trading range.

Сравнение с други в отрасъла

Ценова промяна

DexCom Inc Прогноза

Ценова цел

By TipRanks

2.07% нагоре

12-месечна прогноза

Среден 91.61 USD  2.07%

Висок 105 USD

Нисък 64 USD

Според 20 анализатори от Wall Street, предложили 12-месечна ценова цел за DexCom Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

20 ratings

18

Купи

1

Задържане

1

Продай

Настроение

By Acuity

68 / 340 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
help-icon Live chat